Signal Genetics (SGNL) Tops Q4 EPS by 8c

Signal Genetics (NASDAQ: SGNL) reported Q4 EPS of ($0.28), $0.08 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $659 thousand versus the consensus estimate of $500 thousand.

For earnings history and earnings-related data on Signal Genetics (SGNL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c